Paper28645161
LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145.
Lei H and 2 others. Acta Biochim Biophys Sin (Shanghai), 2017. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Papers, record 28645161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28645161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Papillary | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| MicroRNAs | Major topic |
| RNA, Long Noncoding | Major topic |
| Thyroid Neoplasms | Major topic |
| Cell Movement | |
| Cell Proliferation | |
| Humans | |
| Neoplasm Invasiveness | |
| Thyroid Cancer, Papillary | |
| Zinc Finger E-box-Binding Homeobox 1 |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42110648 | Comprehensive analysis of the lncRNA-miRNA-mRNA ceRNA network in aortic dissection. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42110648 | PubMed |
| 41800331 | LncRNA VCAN-AS1 Sponges miR-374c-3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer. | Int J Endocrinol | 2026 | https://conductscience.org/library/papers/41800331 | PubMed |
| 41150811 | Epigenetic Remodeling in Thyroid Cancer: New Dimensions of Targeted Therapy Through lncRNA Modulation. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150811 | PubMed |
| 40641128 | miR‑145 and miR‑23b co‑transfection decreases proliferation, migration, invasion and protein levels of c‑MYC, ZEB1 and ABCB1 in epithelial ovarian cancer cell lines. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40641128 | PubMed |
| 40530008 | The regulatory network of epithelial-mesenchymal transition-associated non-coding RNAs in thyroid cancer: molecular mechanisms, clinical implications, and therapeutic strategies. | Front Oncol | 2025 | https://conductscience.org/library/papers/40530008 | PubMed |
| 40308809 | LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression. | J Immunol Res | 2025 | https://conductscience.org/library/papers/40308809 | PubMed |
| 39598228 | The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39598228 | PubMed |
| 39558949 | The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39558949 | PubMed |
| 39360313 | GRB7-mediated enhancement of cell malignant characteristics induced by Helicobacter pylori infection. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39360313 | PubMed |
| 39264078 | Linc-ROR Modulates the Endothelial-Mesenchymal Transition of Endothelial Progenitor Cells through the miR-145/Smad3 Signaling Pathway. | Physiol Res | 2024 | https://conductscience.org/library/papers/39264078 | PubMed |
| 39187514 | High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/39187514 | PubMed |
| 38742050 | LINC00115 aggravates thyroid cancer progression by targeting miR-489-3p, which downregulates EVA1A to regulate the Hippo signaling pathway. | Heliyon | 2024 | https://conductscience.org/library/papers/38742050 | PubMed |
| 38001954 | Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer. | Biomedicines | 2023 | https://conductscience.org/library/papers/38001954 | PubMed |
| 37781070 | CSNK1G2-AS1 promotes metastasis, colony formation and serves as a biomarker in testicular germ cell tumor cells. | J Cancer | 2023 | https://conductscience.org/library/papers/37781070 | PubMed |
| 37547301 | New biomarkers: prospect for diagnosis and monitoring of thyroid disease. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37547301 | PubMed |
| 37304549 | Identification and validation of an epithelial-mesenchymal transition-related lncRNA pairs prognostic model for gastric cancer. | Transl Cancer Res | 2023 | https://conductscience.org/library/papers/37304549 | PubMed |
| 36423383 | LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p/IMPA2 axis. | Transl Oncol | 2023 | https://conductscience.org/library/papers/36423383 | PubMed |
| 36398231 | Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/36398231 | PubMed |
| 36111745 | The activation of M 3 muscarinic receptor reverses liver injuryvia the Sp1/lncRNA Gm2199/miR-212 axis. | Acta Biochim Biophys Sin (Shanghai) | 2022 | https://conductscience.org/library/papers/36111745 | PubMed |
| 36093406 | LRSAM1 E3 Ubiquitin Ligase Promotes Choriocarcinoma Progression and Metastasis via p53/p21 Signaling Impediment. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36093406 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR145 | 406937 | PubTator's text mining | https://conductscience.org/library/genes/406937 | NCBI Gene |
| TUG1 | 55000 | PubTator's text mining | https://conductscience.org/library/genes/55000 | NCBI Gene |
| ZEB1 | 6935 | PubTator's text mining | https://conductscience.org/library/genes/6935 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28645161
GET https://conductscience.org/api/papers/v1/28645161/cited_by?page=2